Suboxone
E387494
Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Suboxone canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3781177 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Suboxone Context triple: [Elliot Alderson, counteractsDrugWith, Suboxone]
-
A.
Substiane
Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
-
B.
Nicorette
Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
-
C.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
D.
Novafora
Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
-
E.
Lamotrek
Lamotrek is a small atoll in the Federated States of Micronesia known for its traditional seafaring culture and navigational expertise.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Suboxone Target entity description: Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
-
A.
Substiane
Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
-
B.
Nicorette
Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
-
C.
Anpezan
Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
-
D.
Novafora
Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
-
E.
Lamotrek
Lamotrek is a small atoll in the Federated States of Micronesia known for its traditional seafaring culture and navigational expertise.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
brandNameDrug
ⓘ
combinationDrug ⓘ medication ⓘ |
| approvalFor | treatmentOfOpioidDependence ⓘ |
| approvedBy |
USFoodAndDrugAdministration
ⓘ
linked to:
Food and Drug Administration
|
| chemicalRelationship |
containsBuprenorphineHydrochloride
ⓘ
containsNaloxoneHydrochloride ⓘ |
| containsSubstanceWithClass |
opioidAntagonist
ⓘ
partialMuOpioidReceptorAgonist ⓘ |
| contraindicatedWith |
acuteSevereBronchialAsthma
ⓘ
severeRespiratoryDepression ⓘ |
| developedBy | Indivior ⓘ |
| dosageForm |
sublingualFilm
ⓘ
sublingualTablet ⓘ |
| hasActiveIngredient |
buprenorphine
ⓘ
naloxone ⓘ |
| hasComponentRole |
buprenorphineProvidesOpioidEffect
ⓘ
naloxoneDiscouragesInjectionMisuse ⓘ |
| hasGenericVersion | buprenorphineNaloxone ⓘ |
| indicatedFor |
opioidDependence
ⓘ
opioidUseDisorder ⓘ |
| marketedBy | Indivior ⓘ |
| mayCauseAdverseEffect |
constipation
ⓘ
headache ⓘ insomnia ⓘ nausea ⓘ sedation ⓘ sweating ⓘ |
| monitoringRequirement | liverFunctionMonitoring ⓘ |
| pharmacologicalClass | partialOpioidAgonistCombination ⓘ |
| pregnancyCategory | useOnlyIfBenefitsOutweighRisks ⓘ |
| regulatesReceptor | muOpioidReceptor ⓘ |
| requires |
medicalSupervision
ⓘ
prescription ⓘ |
| risk |
dependence
ⓘ
misuseAndAbuse ⓘ precipitatedWithdrawalInFullAgonistUsers ⓘ respiratoryDepression ⓘ |
| routeOfAdministration |
buccal
ⓘ
sublingual ⓘ |
| schedule | controlledSubstance ⓘ |
| usedFor |
maintenanceTreatmentOfOpioidDependence
ⓘ
reductionOfOpioidCravings ⓘ reductionOfOpioidWithdrawalSymptoms ⓘ |
| usedIn | medicationAssistedTreatment ⓘ |
| usedWith |
counseling
ⓘ
psychosocialSupport ⓘ |
| warning |
riskOfOverdoseIfCombinedWithAlcohol
ⓘ
riskOfOverdoseIfCombinedWithBenzodiazepines ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Suboxone Description of subject: Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.